PCM
NTUS

Piermont Capital Management’s Natus Medical Inc NTUS Stock Holding History

Piermont Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,460
Closed -$390K – 278
2017
Q2 		$390K Sell
10,460
-1,860
-15% -$67.2K 0.11% 239
2017
Q1 		$484K Hold
12,320
– – 0.12% 232
2016
Q4 		$429K Buy
+12,320
New +$484K 0.1% 239

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Piermont Capital Management's NTUS Position: Q3 2017 in Review

Piermont Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 10,460 shares — an estimated $390K sold.

Piermont Capital Management first reported a position in NTUS in Q4 2016 and held it in 3 quarters. The position peaked at $484K in Q1 2017. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

  • Piermont Capital Management reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
  • Piermont Capital Management sold 10,460 Natus Medical Inc shares in Q3 2017, an estimated $390K.
  • Piermont Capital Management first reported a position in Natus Medical Inc in Q4 2016 and held it in 3 quarters.
  • Piermont Capital Management's Natus Medical Inc position peaked at $484K in Q1 2017.
  • 198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on Piermont Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.